Literature DB >> 90135

Primary malignant lymphoma of the CNS and polyneuropathy in a patient with necrotizing vasculitis treated with immunosuppression.

K Jellinger, P Kothbauer, R Weiss, E Sunder-Plassmann.   

Abstract

A woman, aged 58, who had undergone prolonged treatment with corticosteroids for generalized necrotizing vasculitis, and had received azathioprine (Imurel) for 18 months, 4 years after discontinuing the latter treatment, developed peripheral neuropathy and a rapidly progressing cerebral disorder suggesting a basal meningeal process. CSF cytology suggested malignant lymphoma with meningeal involvement. Immunological studies showed an increase of Null-lymphocytes in the peripheral blood. Autopsy disclosed a primary malignant lymphoma of the CNS with the histological appearance of a multilocular immunoblastoma showing almost ubiquitous meningocerebral involvement. Clinical and postmortem examinations failed to demonstrate any systemic extraneural lymphoproliferative disorder. In addition, there was peripheral polyneuropathy of the axonal type with denervation atrophy of skeletal muscle, but without lymphomatous involvement of the neuromuscular system. The possible relations between primary malignant lymphomas of the CNS and previous immunosuppressive treatment of immunoinflammatory disease are discussed in view of the concept of impaired immunoregulation. The pathogenetic background of peripheral polyneuropathy is unknown.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 90135     DOI: 10.1007/BF00314150

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  NEUROMUSCULAR DISORDERS ASSOCIATED WITH MALIGNANT NEOPLASTIC DISEASE.

Authors:  L P ROWLAND; S A SCHNECK
Journal:  J Chronic Dis       Date:  1963-07

Review 2.  Differential diagnosis of neuropathy associated with cancer.

Authors:  P J Dyck; J M Kiely
Journal:  Adv Neurol       Date:  1976

3.  Primary malignant lymphomas of the central nervous system.

Authors:  J M Henry; R R Heffner; S H Dillard; K M Earle; R L Davis
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

4.  The incidence of the non-metastatic neurological syndromes of obscure origin in the reticuloses.

Authors:  S Currie; R A Henson; H G Morgan; A J Poole
Journal:  Brain       Date:  1970       Impact factor: 13.501

5.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

6.  Immunodeficiency in patients with non-Hodgkin lymphomas.

Authors:  S E Jones; K Griffith; P Dombrowski; J A Gaines
Journal:  Blood       Date:  1977-03       Impact factor: 22.113

7.  Post-transplant malignant lymphoma. Distinctive morphologic features related to its pathogenesis.

Authors:  A J Matas; B F Hertel; J Rosai; R L Simmoms; J S Najarian
Journal:  Am J Med       Date:  1976-11       Impact factor: 4.965

8.  Intracranial reticulum cell sarcoma associated with immunoglobulin A deficiency.

Authors:  M C Gregory; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

9.  Neuropathy associated with lymphoma.

Authors:  J C Walsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-02       Impact factor: 10.154

10.  Systemic lupus erythematosus and lymphoma.

Authors:  J A Green; A A Dawson; W Walker
Journal:  Lancet       Date:  1978-10-07       Impact factor: 79.321

View more
  8 in total

1.  Membranous changes in primary malignant CNS lymphomas.

Authors:  F Slowik; K Jellinger
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 2.  [Primary CNS lymphoma in azathioprine therapy for autoimmune diseases: review of the literature and case report].

Authors:  F Kästner; W Paulus; M Deckert; P Schlegel; S Evers; I W Husstedt
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

3.  Selective immunodeficiency and malignant lymphoma of the central nervous system. Possible relationship to the Epstein-Barr virus.

Authors:  P K Pattengale; C R Taylor; T Panke; D Tatter; R A McCormick; D G Rawlinson; R L Davis
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

Review 4.  Primary hypothalamic lymphoma in a patient with systemic lupus erythematosus: case report and review of the literature.

Authors:  Antonella Biasiotta; Alessandro Frati; Maurizio Salvati; Antonino Raco; Maurizio Fazi; Alessandro D'Elia; Giorgio Cruccu
Journal:  Neurol Sci       Date:  2010-06-29       Impact factor: 3.307

Review 5.  Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification.

Authors:  C Vital; A Vital; J Julien; J Rivel; A deMascarel; B Vergier; P Henry; M Barat; J Reiffers; A Broustet
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

Review 6.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

7.  Progressive multifocal leukoencephalopathy and malignant lymphoma of the brain in a patient with immunosuppressive therapy.

Authors:  K Ho; J C Garancis; R D Paegle; M A Gerber; W J Borkowski
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

8.  Primary meningeal B lymphoma presenting as a subacute ascending polyradiculoneuropathy.

Authors:  J Julien; C Vital; J Rivel; A de Mascarel; A Lagueny; X Ferrer; B Vergier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.